169 related articles for article (PubMed ID: 2038014)
21. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
[TBL] [Abstract][Full Text] [Related]
22. The evolution of arthritis antiinflammatory care: where are we today?
Simon LS
J Rheumatol Suppl; 1999 Apr; 56():11-7. PubMed ID: 10225535
[TBL] [Abstract][Full Text] [Related]
23. [A NSAID-associated alimentary tract disease in patients with rheumatism in Russia].
Karataev AE; Konovalova NN; Litovshenko AA; Lomareva NI; Nemtsov BF; Raskina TA; Peshekhonova LK; Nasonov EL
Klin Med (Mosk); 2005; 83(5):33-8. PubMed ID: 15984580
[TBL] [Abstract][Full Text] [Related]
24. GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugs.
Harris CL; Raisch DW; Abhyankar U; Marfatia S; Campbell HM; Sather MR
Ann Pharmacother; 2006 Nov; 40(11):1924-31. PubMed ID: 17047140
[TBL] [Abstract][Full Text] [Related]
25. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
Steen KS; Lems WF; Dijkmans BA
Ned Tijdschr Geneeskd; 1999 Aug; 143(32):1649-52. PubMed ID: 10494299
[TBL] [Abstract][Full Text] [Related]
26. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
Vakil N
Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894
[TBL] [Abstract][Full Text] [Related]
27. [The assessment of the effect of glucocorticosteroid and nonsteroidal anti-inflammatory preparations on the development of an erosive-ulcerative lesion of the gastrointestinal tract in patients with rheumatic diseases].
Karateev AE; Nasonova VA; Murav'ev IuV
Ter Arkh; 1999; 71(2):26-30. PubMed ID: 10222549
[TBL] [Abstract][Full Text] [Related]
28. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models.
Fries JF; Williams CA; Bloch DA; Michel BA
Am J Med; 1991 Sep; 91(3):213-22. PubMed ID: 1892140
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of NSAID induced gastrointestinal complications.
Singh G; Triadafilopoulos G
J Rheumatol Suppl; 1999 Apr; 56():18-24. PubMed ID: 10225536
[TBL] [Abstract][Full Text] [Related]
30. The hidden cost of nonselective nonsteroidal antiinflammatory drugs in older patients.
Solomon DH; Glynn RJ; Bohn R; Levin R; Avorn J
J Rheumatol; 2003 Apr; 30(4):792-8. PubMed ID: 12672201
[TBL] [Abstract][Full Text] [Related]
31. Practical management of NSAID gastropathy in rheumatic patients.
Peltier AP
Scand J Rheumatol Suppl; 1989; 78():12-7; discussion 30-2. PubMed ID: 2786645
[TBL] [Abstract][Full Text] [Related]
32. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
33. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use.
Lanas A; Perez-Aisa MA; Feu F; Ponce J; Saperas E; Santolaria S; Rodrigo L; Balanzo J; Bajador E; Almela P; Navarro JM; Carballo F; Castro M; Quintero E;
Am J Gastroenterol; 2005 Aug; 100(8):1685-93. PubMed ID: 16086703
[TBL] [Abstract][Full Text] [Related]
34. NSAID and gastropathy: a rheumatologist's review.
Roth SH
J Rheumatol; 1988 Jun; 15(6):912-9. PubMed ID: 3047383
[TBL] [Abstract][Full Text] [Related]
35. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.
Chan FK; Abraham NS; Scheiman JM; Laine L;
Am J Gastroenterol; 2008 Nov; 103(11):2908-18. PubMed ID: 18853980
[TBL] [Abstract][Full Text] [Related]
36. Influence of age and disease state in nonsteroidal antiinflammatory drug associated gastric bleeding.
Llewellyn JG; Pritchard MH
J Rheumatol; 1988 Apr; 15(4):691-4. PubMed ID: 3397979
[TBL] [Abstract][Full Text] [Related]
37. Non-steroidal anti-inflammatory drugs--uses and complications.
Ng SC
Singapore Med J; 1992 Oct; 33(5):510-3. PubMed ID: 1455279
[TBL] [Abstract][Full Text] [Related]
38. [Is there still a role for standard nonsteroidal antirheumatic agents?].
Laktasić-Zerjavić N
Reumatizam; 2001; 48(2):24-6. PubMed ID: 12476744
[TBL] [Abstract][Full Text] [Related]
39. Nonsteroidal antiinflammatory drug use among patients with GI bleeding.
Dominick KL; Bosworth HB; Jeffreys AS; Grambow SC; Oddone EZ; Horner RD
Ann Pharmacother; 2004; 38(7-8):1159-64. PubMed ID: 15187205
[TBL] [Abstract][Full Text] [Related]
40. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.
Laine L; Connors LG; Reicin A; Hawkey CJ; Burgos-Vargas R; Schnitzer TJ; Yu Q; Bombardier C
Gastroenterology; 2003 Feb; 124(2):288-92. PubMed ID: 12557133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
